Women’s risk of hypertension and cardiovascular disease subtypes by number of cycles of assisted reproductive technologies: a Norwegian registry-linkage study - Top-Institutions - MDSpire

Women’s risk of hypertension and cardiovascular disease subtypes by number of cycles of assisted reproductive technologies: a Norwegian registry-linkage study

  • By

  • Huong Thu Nguyen

  • Hans Ivar Hanevik

  • Abigail Fraser

  • Deborah A Lawlor

  • Kari Furu

  • Jacqueline M Cohen

  • Maria C Magnus

  • December 3, 2025

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Reproductive Endocrinology
    • Cardiology
    • Epidemiology

  • #2

    Harvard Medical School / Brigham and Women's Hospital
    Harvard Medical School / Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Reproductive Medicine
    • Cardiovascular Epidemiology
    • Public Health

  • #3

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Stockholm County

    Key Differentiators

    • Reproductive Medicine
    • Cardiovascular Research
    • Registry-Based Epidemiology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Reproductive Endocrinology
    • Cardiology
    • Women's Health

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Reproductive Medicine
    • Epidemiology

Original Source(s)

Women’s risk of hypertension and cardiovascular disease subtypes by number of cycles of assisted reproductive technologies: a Norwegian registry-linkage study

  • by Huong Thu Nguyen, Hans Ivar Hanevik, Abigail Fraser, Deborah A Lawlor, Kari Furu, Jacqueline M Cohen, Maria C Magnus

  • December 3, 2025

Related Content

Myocardial infarction following fluorescein angiography: a case report and review of the literature

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.